Eurecat seeks to identify key biomarkers in major depression to increase diagnosis and treatment accuracy
The Eurecat technology centre is working in the European OPADE project for the identification of key biomarkers in major depressive disorder to support healthcare professionals in their decision-making and increase the accuracy of diagnosis and antidepressant treatment. Specifically, the Eurecat research team is analysing multi-omics data from hundreds of patients with severe depression “to find [...]









